| Metric | შპს ნიუ ფარმა NEW PHARMA | შპს სანდო ფარმა |
|---|---|---|
| Growth | ||
| Revenue | ₾883₾4.1m | ₾1.3m₾4.9m |
| Revenue growth | -100.0% | -72.8% |
| Profitability | ||
| EBITDA | -₾262k-₾476k | -₾369k-₾103k |
| EBITDA margin | -29687.2%-11.6% | -27.5%-2.1% |
| Net profit | -₾258k-₾726k | -₾369k-₾103k |
| Net margin | -29249.2%-17.7% | -27.5%-2.1% |
| Balance sheet | ||
| Total assets | ₾83k₾1.4m | ₾684k₾702k |
| Total equity | -₾780k-₾522k | -₾157k₾212k |
| ROE | — | —-48.4% |